Quantcast

PapGene awarded $2.2M NIH contract

PapGene Inc., a privately-held Baltimore-based molecular diagnostic company commercializing advanced molecular tests, announced that it was recently awarded a Fast-Track Small Business Innovation Research contract from the National Cancer Institute of the National Institutes of Health to commercialize a test ...

Read More »